Rohit Dhall
Affiliations: | 2007-2009 | Neurology | University of Alabama, Birmingham, Birmingham, AL, United States |
Google:
"Rohit Dhall"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| McGarry A, Rosanbalm S, Leinonen M, et al. (2023) Safety, tolerability, and efficacy of NLY01 in early untreated Parkinson's disease: a randomised, double-blind, placebo-controlled trial. The Lancet. Neurology. 23: 37-45 |
| Olanow CW, Hauser RA, Burdick DJ, et al. (2023) A Randomized Phase 3 Study Comparing P2B001 to its Components (Low-Dose Extended-Release Rasagiline and Pramipexole) and to Optimized Doses of Marketed Extended-Release Pramipexole in Early Parkinson's Disease. Movement Disorders : Official Journal of the Movement Disorder Society |
| Elberson B, Scott H, Dhall R, et al. (2023) Impedance trend from a symptomatic perielectrode cystic cavity following deep brain stimulation: illustrative case. Journal of Neurosurgery. Case Lessons. 6 |
| LeWitt P, Ellenbogen A, Burdick D, et al. (2023) Improving levodopa delivery: IPX203, a novel extended-release carbidopa-levodopa formulation. Clinical Parkinsonism & Related Disorders. 8: 100197 |
| Pfeifer KJ, Cook AJ, Yankulova JK, et al. (2021) Clinical Efficacy and Dosing of Vibrotactile Coordinated Reset Stimulation in Motor and Non-motor Symptoms of Parkinson's Disease: A Study Protocol. Frontiers in Neurology. 12: 758481 |
| Pfeifer KJ, Kromer JA, Cook AJ, et al. (2021) Coordinated Reset Vibrotactile Stimulation Induces Sustained Cumulative Benefits in Parkinson's Disease. Frontiers in Physiology. 12: 624317 |
| Virmani T, Glover A, Pillai L, et al. (2021) Utility of objective gait measures in levodopa-unresponsive freezing in Parkinson's. Clinical Case Reports. 9: 1072-1077 |
| Grosset DG, Dhall R, Gurevich T, et al. (2019) Inhaled levodopa in Parkinson's disease patients with OFF periods: A randomized 12-month pulmonary safety study. Parkinsonism & Related Disorders. 71: 4-10 |
| Morgan JC, Dhall R, Rubens R, et al. (2018) Dosing Patterns during Conversion to IPX066, Extended-Release Carbidopa-Levodopa (ER CD-LD), in Parkinson's Disease with Motor Fluctuations. Parkinson's Disease. 2018: 9763057 |
| Santiago A, Langston JW, Gandhy R, et al. (2018) Qualitative Evaluation of the Personal KinetiGraphTM Movement Recording System in a Parkinson's Clinic. Journal of Parkinson's Disease |